Versant Ventures Announces Milestone with Recent Northern Biologics and BlueRock Therapeutics Deals

TORONTO & MONTREAL & VANCOUVER, British Columbia December 19, 2016 -Versant Ventures today announced that Toronto-based portfolio company Northern Biologics Inc. has executed a transformational deal that expands its pipeline and financial resources, bringing commitments to Versant’s Canadian biotech portfolio to over CAD$500 million.

Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing

LEVERKUSEN, Germany and BOSTON and NEW YORK and TORONTO and KYOTO, Japan, Dec. 12, 2016 - Bayer AG and Versant Ventures today announced the launch of BlueRock Therapeutics, a next-generation regenerative medicine company that plans to develop best-in-class induced pluripotent stem cell (iPSC) therapies to cure a range of diseases using an industry-leading platform. BlueRock Therapeutics will be led by a world-class team and has assembled its platform through a series of strategic partnerships with academia and industry.

OBIO Announces New Public Relations & Communications Services Member Benefit

TORONTO, Dec. 7, 2016  - HOWE&WYE is proud to announce its new partnership with OBIO®. As a part of OBIO's new member benefit, HOWE&WYE will provide strategic public relations and communications services to OBIO's broad membership of world-class start-ups and bioscience companies. OBIO members will benefit from special access to top-tier agency support with optimized pricing to strengthen PR and marketing to fulfill strategic business outcomes for awareness, investment and commercialization.

OBIO® Launches the Health 2 Business Bridge Program™ H2BB™ Improving Access to Business Trained Talent in Ontario’s Health Science Industry

Toronto, Ontario, December 6, 2016 – Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit, membership based organization, that is Ontario’s leading advocate for the health science industry, hosted its Annual Public Meeting with the theme centered on “Bridging the Access to Talent Gap” at Norton Rose Fulbright LLP yesterday. The OBIO Annual Public Meeting provided a platform to highlight OBIO’s accomplishments made in 2016, upcoming initiatives for 2017 and an opportunity to hear from Parliamentary Assistant to the Minister of Economic Development and Growth, Cristina Martins and Members of the OBIO MPP Health Science Caucus, MPP Shafiq Qaadri and MPP Bill Walker, who welcomed networking with over 60 health science industry professionals.

The evening focused on a vision of collaboration across health science companies and highlighted the supportive partnership that the Province of Ontario has with OBIO.  The evening also marked the launch of the OBIO Health to Business Bridge™ H2BB™ internship program.  OBIO H2BB™ is a program in support of improving access to business trained talent in Ontario’s health science sector, ultimately contributing to a sustainable innovation economy. 

The H2BB™ internship program will combine OBIO’s deep-rooted relationships across academia and industry to develop industry ready talent that strengthens business development capabilities in Ontario’s health science companies, and ultimately amplifies the innovation capability of the province. 

OBIO’s ongoing dialogue with industry has identified access to industry ready business talent as a challenge for health science companies seeking to scale up and commercialize their technologies. The OBIO H2BB™ Program is intended to benefit all participants, interns and industry companies alike, to facilitate development of our knowledge economy and create leadership that understands emerging technology trends to ultimately achieve multipliers of job creation.
— Gail Garland, CEO, OBIO

OBIO H2BB™ provides companies with a unique opportunity to access new talent, while assisting with critical business projects.  Interns will rapidly develop knowledge and insight into new and ultimately profitable technologies. 

Program Participation

Participation in OBIO H2BB™ is open to all Ontario companies developing health science products or services, who are interested in hiring a business trained intern to help complete a managerial project for a minimum duration of four-months. Interested companies are encouraged to contact OBIO to discuss their interest. 

About OBIO

The Ontario Bioscience Innovation Organization (OBIO®) is a not-for-profit, membership-based organization engaged in the development of an integrated health innovation economy for Ontario and one that will become a global leader in providing health technology products and services to the international marketplace.  OBIO advances this goal through advocacy, promotion and strategic leadership and via collaborative partnerships with industry, academia, patients and government.

For more information, visit the OBIO website www.obio.ca and follow OBIO on Twitter @OBIOscience.

OBIO Contacts

Eric Dolinar
Program Manager, Health to Business Bridge
ericdolinar@obio.ca
416-848-6839 ext. 107     

Gail Garland
President and Chief Executive Officer, OBIO
gailgarland@obio.ca
416-848-6839 ext. 101

Pre-CAAP Company: Sojourn Labs Awarded $50,000 to Advance Their Technology in Support of a Lower-Carbon Future for Canada

Shell Canada's Quest Climate Grant has awarded three Canadian clean technology innovations with $50,000 per project to recognize their efforts in helping to combat climate change. The recipients were chosen based on their unique business and/or product concept and their commitment to working on promising climate change innovations.